Nordidemnin potently inhibits inositol uptake in cultured astrocytes and dose-dependently augments lithium's proconvulsant effect in vivo

Journal of Neuroscience Research

Volumn 60, Issue 1, 2000, Pages 116-121

  Wolfson, M ^a   Einat, H ^a   Bersudsky, Y ^a   Berkin, V ^a   Belmaker, R H ^a   Hertz, L ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Astrocytes; Inositol; Lithium; Nordidemnin; Seizure models

Indexed keywords

INOSITOL; LITHIUM; NORDIDEMNIN; PEPTIDE DERIVATIVE; PILOCARPINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0034106576     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000401)60:1<116::AID-JNR12>3.0.CO;2-U     Document Type: Article

References (47)

1. Agam G, Balfour N, Shapiro H, Belmaker RH. 1995. Plasma inositol levels in lithium-treated manic-depressives, schizophrenics and controls. Hum Psychopharmacol 10:311-314.
2. Allison JH, Stewart MA. 1971. Reduced brain inositol m lithium-treated rats. Nature New Biol 233:267-268.
3. Belmaker RH, Agam G, van Calker D, Richards MH, Kofman O. 1998. Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients. Neuropsychopharmacology 19:220-232.
4. Berridge MJ, Downes CP, Hanley MR. 1982. Lithium amplifies agonist-dependent phosphatidyl-inositol responses in brain and salivary glands. Biochem J 206:587-595.
5. Berridge MJ, Downes CP, Hanley MR. 1989. Neural and developmental action of lithium: a unifying hypothesis, Cell 59:411-419.
6. Bersudsky Y, Shapiro J, Agam G, Kofman CX Belmaker RH. 1994. Behavioral evidence for the existence of two pools of cellular inositol. Eur Neuropsychopharmacol 4:463-467.
7. Bordey A, Sontheimer H. 1998. Properties of human glial cells associated with epileptic seizure foci. Epilepsy Res 32:286-303.
8. Brand A, Richter-Landsberg C, Leibfritz D. 1993. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289-298.
9. 2+], in astrocytes by chronic treatment with a therapeutically relevant lithium concentration. Brain Res 711:245-248.
10. Chen Y, Hertz L. 1999. Noradrenaline effects on pyruvate decarboxylation - correlation with calcium signaling. J Neurosci Res, 58:599-606.
11. Chen Y, McNeill JR, Hajek I, Hertz L 1992 Effect of vasopressin on brain swelling at the cellular level - do astrocytes exhibit a furosemide-vasopressin-sensitive mechanism for volume regulation? Can J Physiol Pharmcol 70:S367-S373.
12. Davson, H. 1970. A textbook of general physiology, 4th ed. London: J and A Churchill. p.731.
13. Dominice C, Dufour MN, Patino N, Manzoni O, Grazzini E, Jouin P, Guillon G. 1994. Dual effects of nordidemnin on WRK1 cells: inhibition of phosphoinositide metabolism and cell proliferation. J Pharm Exp Ther 271:107-117.
14. Dorr FA, Kuhn JG, Phillips J, von Hoff DD. 1988 Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptide. Eur J Cancer Clin Oncol 24:1699-1706.
15. Einat H, Kofman O, Itkin O, Lewitan RJ, Belmaker RH. 1998. Augmentation of lithium's behavioral effect by inositol uptake inhibitors. J Neural Trans 105:31-38.
16. Einat H, Karbovski H, Korik J, Tsalah D, Belmaker RH. 1999. Inositol reduces depressive-like behaviors in two different animal models of depression. Psychopharmacology 144:158-162.
17. Ghersi-Egea JF, Finnegan W, Chen JL, Fenstermacher JD. 1996. Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat. Neuroscience 75:1271-1288.
18. Glanville NT, Byers DM, Cook HV, Spence MW, Palmer FD StC. 1989. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta 1004:169-179.
19. Harsh GR, Nishimura RN, Dwyer BE, Levin VA. 1986. L-fucose labeling of brain tumors in rats. Exp Neurol 94:21-28.
20. Hertz L. 1992. Autonomic control of metabolic activities and ion fluxes in the CNS. Brain Res Bull 29:303-338.
21. Hertz L, Peng L. 1992. Effects of monoamine transmitters on neurons and astrocytes: correlation between energy metabolism and intracellular messengers. Prog Brain Res 94:283-301.
22. Hertz L, Juurlink BHJ, Szuchet S. 1985. Cell cultures. In: Lajtha A, editor. Handbook of neurochemistry, 2nd edition, Vol. 8. New York: Plenum Press. pp 603-651.
23. Hertz L, Wolfson M, Hertz E, Agam G, Richards M, Belmaker RH. 1997. Lithium/inositol interactions. In: Van Praag HM, Honig A, editors. Depression: neurobiological, psychopathological and therapeutic advances. New York: Wiley. pp 519-534.
24. Hertz L, Lai JCK, Peng L. 1998. Functional studies in cultured astrocytes. Methods Companion Methods Enzymol 16:293-310.
25. Hertz L, Dringen R, Schousboe A, Robinson SR. 1999. Astrocytes: glutamate producers for neurons. J Neurosci Res 57:417-428
26. Honchar MP, Olney JW, Sherman WR (1983) Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science 220: 323-325.
27. Isaacks RE, Bender AS, Kim CY, Shi YF Norenberg MD. 1999a. Effect of ammonia and methionine sulfoximine on myo-inositol transport in cultured astrocytes. Neurochein Res 24:51-59.
28. Isaacks RE, Bender AS, Reuben JS, Kim CY, Shi YF Norenberg MD. 1999b. Effect of dibutyryl cyclic AMP on the kinetics of myo-inositol transport in cultured astrocytes. J Neurochem 73:105-111.
29. Jouin P, Poncet J, Dufour AA, Pantaloni A. 1991. Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues. J Med Chem 34:486-491.
30. Juurlink BHJ, Hertz L. 1992. Astrocytes. In: Boulton AA, Baker GB, Walz W, editors. Neuromethods, Vol. 23, Cell Cultures. Clifton, NY: Humana Press. pp 269-321.
31. Kofman O, Sherman WR, Katz V, Belmaker RH. 1993. Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures. Psychopharmacology 110:229-234.
32. Lee SH, Magge S, Spencer DD, Sontheimer H, Cornell-Bell A. 1995. Human epileptic astrocytes exhibit increased gap junction coupling. GLIA 15:195-202.
33. Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, Belmaker RH. 1995. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiat 152:792-794.
34. Lubrich B, van Calker D. 1999. Inhibition of the high-affinity myo-inositol uptake: a common mechanism of action of antibipolar drugs? Neuropsychopharmacology 21:519-529.
35. Meier E, Hertz L, Schousboe A. 1991. Neurotransmitters as developmental signals. Neurochem Int 19:1-15.
36. Osborne PG, Denton DA, Weisinger RS. 1986. Cerebrospinal fluid pressure of anaesthetized rats during intracerebroventricular infusion. Physiol Behav 37:1-4.
37. Pesando D, Dominice C, Dufour MN, Guillon G, Jouin P, Ciapa B. 1995. Effect of nordidemnin on the cell cycle of sea urchin embryos. Role in synthesis and phosphorylation of proteins and in polyphosphoinositide turnover in mitosis progression. Exp Cell Res 220:18-28.
38. Smith SJ. 1992. Do astrocytes process neural information? Prog Brain Res 94:119-136.
39. Tricklebank MD, Singh L, Jackson A, Oles RJ. 1991. Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain. Brain Res 558:145-148.
40. Ullrich A, Baierl P, ten Bruggencate G. 1980. Extracellular potassium in rat cerebellar cortex during acute and chronic lithium application. Brain Res 192:287-290.
41. Walz W, Hertz L. 1982. Acute and chronic effects of lithium in therapeutically relevant concentrations on potassium uptake into astrocytes. Psyclopharmacology 78: 309-313.
42. Walz W, Hertz E, Hertz L. 1983. Lithium - potassium interaction in acutely treated cortical neurons and astrocytes. Prog Neuropsychopharmacol Biol Psychiat 7:697-702.
43. Westergaard N, Sonnewald U, Schousboe. 1995. Metabolic trafficking between neurons and astrocytes: the glutamate/glutamine cycle revisited. Dev Neurosci 17:203-211.
44. Wiesinger H. 1991. myo-Inositol transport in mouse astroglia-rich primary cultures. J Neurochem 56:1698-1704.
45. Wolfson M, Hertz E, Belmaker RH, Hertz L. 1998. Chronic treatment with lithium and pretreatment with excess inositol reduce inositol pool sizes by different mechanisms. Brain Res 787:34-40.
46. Wolfson M, Bersudsky J, Zinger E, Simkin M., Belmaker RH, Hertz L. 2000. Chronic treatment of human astrocytoma cells with lithium, carhamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations. Brain Res. 855:158-161.
47. Yorek MA, Dunlap JA, Stefani MR, Davidson EP, Zhu X, Eichberg J. 1994. Decreased myo-inositol uptake is associated with reduced bradykinin-stimulated phosphatidylinositol synthesis and diacylglycerol content in cultured neuroblastoma cells exposed to L-fucose. J Neurochem 62:147-158.